| Enteral nutritional therapy for induction of remission in Crohn's disease N Narula, A Dhillon, D Zhang, ME Sherlock, M Tondeur, M Zachos Cochrane database of systematic reviews, 2018 | 1109 | 2018 |
| Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease SC Shah, JF Colombel, BE Sands, N Narula Alimentary pharmacology & therapeutics 43 (3), 317-333, 2016 | 375 | 2016 |
| Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis SC Shah, JF Colombel, BE Sands, N Narula Clinical gastroenterology and hepatology 14 (9), 1245-1255. e8, 2016 | 340 | 2016 |
| The real-world effectiveness and safety of vedolizumab for moderate–severe Crohn’s disease: results from the US VICTORY Consortium PS Dulai, S Singh, X Jiang, F Peerani, N Narula, K Chaudrey, ... Official journal of the American College of Gastroenterology| ACG 111 (8 …, 2016 | 328 | 2016 |
| Management strategies to improve outcomes of patients with inflammatory bowel diseases JF Colombel, N Narula, L Peyrin-Biroulet Gastroenterology 152 (2), 351-361. e5, 2017 | 323 | 2017 |
| Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study N Narula, ECL Wong, M Dehghan, A Mente, S Rangarajan, F Lanas, ... Bmj 374, 2021 | 244 | 2021 |
| Systematic review and meta-analysis: fecal microbiota transplantation for treatment of active ulcerative colitis N Narula, Z Kassam, Y Yuan, JF Colombel, C Ponsioen, W Reinisch, ... Inflammatory bowel diseases 23 (10), 1702-1709, 2017 | 244 | 2017 |
| Systematic review and meta-analysis: infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids N Narula, JK Marshall, JF Colombel, GI Leontiadis, JG Williams, ... Official journal of the American College of Gastroenterology| ACG 111 (4 …, 2016 | 204 | 2016 |
| Meta‐analysis: peri‐operative anti‐TNF α treatment and post‐operative complications in patients with inflammatory bowel disease N Narula, D Charleton, JK Marshall Alimentary pharmacology & therapeutics 37 (11), 1057-1064, 2013 | 174 | 2013 |
| Open: Vedolizumab for ulcerative colitis: treatment outcomes from the VICTORY consortium N Narula, F Peerani, J Meserve, G Kochhar, K Chaudrey, J Hartke, ... Official journal of the American College of Gastroenterology| ACG 113 (9), 1345, 2018 | 158 | 2018 |
| Systematic review: safety of mesalazine in ulcerative colitis P Sehgal, JF Colombel, A Aboubakr, N Narula Alimentary pharmacology & therapeutics 47 (12), 1597-1609, 2018 | 150 | 2018 |
| Development and validation of a scoring system to predict outcomes of vedolizumab treatment in patients with Crohn’s disease PS Dulai, BS Boland, S Singh, K Chaudrey, JL Koliani-Pace, G Kochhar, ... Gastroenterology 155 (3), 687-695. e10, 2018 | 137 | 2018 |
| Exercise and inflammatory bowel disease N Narula, RN Fedorak Canadian Journal of Gastroenterology and Hepatology 22 (5), 497-504, 2008 | 109 | 2008 |
| Impact of high-dose vitamin D3 supplementation in patients with Crohn’s disease in remission: a pilot randomized double-blind controlled study N Narula, M Cooray, R Anglin, Z Muqtadir, A Narula, JK Marshall Digestive diseases and sciences 62, 448-455, 2017 | 101 | 2017 |
| Systematic review: sequential rescue therapy in severe ulcerative colitis: do the benefits outweigh the risks? N Narula, M Fine, JF Colombel, JK Marshall, W Reinisch Inflammatory bowel diseases 21 (7), 1683-1694, 2015 | 99 | 2015 |
| Anti-TNFα therapies are safe during pregnancy in women with inflammatory bowel disease: a systematic review and meta-analysis N Narula, R Al-Dabbagh, A Dhillon, BE Sands, JK Marshall Inflammatory bowel diseases 20 (10), 1862-1869, 2014 | 98 | 2014 |
| dose optimisation of infliximab for acute severe ulcerative colitis P Hindryckx, G Novak, N Vande Casteele, D Laukens, C Parker, ... Alimentary pharmacology & therapeutics 45 (5), 617-630, 2017 | 97 | 2017 |
| Systematic review and meta-analysis: preoperative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease CCY Law, A Narula, AL Lightner, NP McKenna, JF Colombel, N Narula Journal of Crohn's and Colitis 12 (5), 538-545, 2018 | 95 | 2018 |
| Early life exposures and the risk of inflammatory bowel disease: systematic review and meta-analyses M Agrawal, J Sabino, C Frias-Gomes, CM Hillenbrand, C Soudant, ... EClinicalMedicine 36, 2021 | 91 | 2021 |
| Management of inflammatory bowel disease with vitamin D: beyond bone health N Narula, JK Marshall Journal of Crohn's and Colitis 6 (4), 397-404, 2012 | 84 | 2012 |